“Prescription drug prices are out of control,” wrote AHA President and CEO Rick Pollack and America’s Health Insurance Plans President and CEO Marilyn Tavenner in a Dec. 31 OpEd in The Hill. “The average annual cost for one specialty medication to treat a chronic condition is now more than what most families earn in a year. Big Pharma could solve the problem by committing to more rational and sustainable pricing models. Instead, for the last year, Big Pharma has chosen to point the finger at everyone else, and their decision to engage in a blame game is a tacit admission that drug prices are, in fact, too high.” To read the full column, click here.

Related News Articles

Headline
In continuing recognition of Mental Health Awareness Month, Azziza Bankole, M.D., writes about the negative effects of social isolation and loneliness and how…
Blog
Exploring and developing a better understanding of the social determinants of health is becoming standard in medical education and training. Social isolation…
Headline
The Centers for Medicare & Medicaid Services May 9 announced an extension of unwinding flexibilities to support state efforts to protect the continuity of…
Perspective
Hospitals hold an extraordinary place in our society by offering comfort and caring to all who walk through their doors, regardless of ability to pay.While the…
Headline
Two experts from AdventHealth discuss how its “Be a Mindleader” campaign is leading the way to improving adolescent mental health by helping parents and kids…
Headline
In a statement submitted May 8 for a Senate Budget Committee hearing on reducing administrative burden in health care, AHA urged Congress to streamline the…